Corcept Therapeutics Inc (CORT) income statement
CORTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/30309% above fair value
$63.62−1.36 (-2.09%)
Close on Nov 20, 2026Market cap $6.88BP/E 151.5Yield –
Corcept Therapeutics Inc financial ratios
See a number that looks wrong?